Rehabilitation Robotics After a Stroke
Launched by UNIVERSITY HOSPITAL, BREST · Jun 27, 2011
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ischemic or hemorrhagic stroke of the middle cerebral arteria territory
- • 18 to 80 years old
- • stroke onset between 3 weeks to 3 months,with or without aphasia, with or without lateral neglect and homonymous hemianopia, with or without visual neglect
- • 10\<or= Fugl Meyer upper limb Score \<or= 40
- • upper limbs pain less or equal than 3/10 (VAS)
- • inpatient or outpatient rehabilitation
- • signed inform consent
- Exclusion Criteria:
- • ischemic or hemorrhagic stroke of anterior or posterior cerebral artery
- • ischemic or hemorrhagic stroke of the brainstem
- • major aphasia evaluated by a Boston Diagnostic Aphasia Examination (BDAE) score less or equal to 3
- • asthenia not allowing to work 60 minutes with the robot.
- • serious visual deficiency not allowing to use the robot
- • impossibility to install the arm on the robot because of a serious and uncontrolled spasticity or for any other reason
- • pronounced and constant muscular contractures, or deformation affecting the use of the extremity
- • upper limb's pain superior to 3/10 and/or being worse at the active and passive mobilization
- • serious infection and/or instability of vital functions
- • perfusion of the affected upper limb not removable
- • incapacity to stay on a chair
- • contraindicated sitting position
- • permanent deviation of the head and\\or of the eyes
- • perturbed or non-cooperative patient
- • patients that must have to be isolated due to an infection process
- • bone fracture of the paretic limb with an onset less than 3 months stabilized or not
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limoges, , France
Nantes, , France
Toulouse, , France
Amiens, , France
Lille, , France
Brest, , France
Bordeaux, , France
Reims, , France
Paris, , France
Dijon, , France
Lyon, , France
Angers, , France
Cerbere, , France
Clermont Ferrand, , France
Garches, , France
Granville, , France
Le Grau Du Roi, , France
Marseille, , France
Montpellier, , France
Nancy, , France
Paris, , France
Ploemeur, , France
Rennes, , France
Patients applied
Trial Officials
Olivier REMY-NERIS, Professor
Principal Investigator
University Hospital, Brest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials